<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "etoposide cap">
<dose><value>200</value>
<value>150</value>
</dose>
<route><value>PO</value>
</route>
<strength><value>50 mg</value>
</strength>
<frequency><value>DAILY</value>
</frequency>
<instruction><value>DAY 2 &amp; 3 of 21. DAILY for 2 days.</value>
<value>DAYS 2 &amp; 3 of 21. DAILY for 2 days.</value>
<value>DAYS 1 - 5 of 21. DAILY for 5 days.</value>
</instruction>
<volume></volume>
<units><value>mg/m2/day</value>
<value>mg</value>
</units>
<Population><value>CISplatin/etoposide (po). Small Cell Lung Cancer</value>
<value>CARBOplatin/Etoposide (IV/po). Small Cell Lung Cancer</value>
<value>Etoposide (po) SCLC-Prov. Small Cell Lung Cancer</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes><value>Dose rounded off to nearest 50 mg.</value>
</AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=3390</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary.</value>
</AHSFormularyStatus>
<AHFSName><value>Antineoplastic Agents</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>